The IVF-generated human embryonic microenvironment reverses progestin resistance in endometrial cancer cells by inducing cancer stem cell differentiation-Reference-Cited by-同舟云学术

The IVF-generated human embryonic microenvironment reverses progestin resistance in endometrial cancer cells by inducing cancer stem cell differentiation

Published:2022-02 Issue: Volume:526 Page:311-321
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Sun Di^ORCID,Qin Zuoshu,Xu Yuan,Xiao Qimeng,Xu Yiqing,Bai Mingzhu,Li Wen,Liu Yong,Zheng Wenxin,Zhang Zhenbo

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference63 articles.

1. Cancer statistics, 2009;Jemal;Ca - Cancer J. Clin.,2009

2. High-risk endometrial cancer in young indigent women;Ben-Arie;Int. J. Gynecol. Cancer,2004

3. Combined medroxyprogesterone acetate/levonorgestrel-intrauterine system treatment in young women with early-stage endometrial cancer;Kim;Am. J. Obstet. Gynecol.,2013

4. Combined modality adjuvant therapy for high-risk endometrial cancer;Vanderstichele;Lancet Oncol.,2016

5. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up;Colombo;Ann. Oncol.,2016

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I Inhibitor;Antioxidants;2024-06-17

2. Unveiling the mechanisms and challenges of cancer drug resistance;Cell Communication and Signaling;2024-02-12

3. TSLP enhances progestin response in endometrial cancer via androgen receptor signal pathway;British Journal of Cancer;2024-01-03

4. Unveiling Residual Diseases of Endometrial Precancer/Cancer After Progestin Therapy;Gynecologic and Obstetric Pathology;2024

5. Endometrial Carcinogenesis;Gynecologic and Obstetric Pathology;2024